Want to see SE:ORGC full AI Analyst Report?
ORGC Stock Chart & Stats
kr1.78
kr0.00(0.00%)
At close: 4:00 PM EST
kr1.78
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr0.30 - kr2.07
Previous CloseN/A
Volume11.05K
Average Volume (3M)87.89K
Market Cap
kr87.76M
Enterprise Valuekr216.62
Total Cash (Recent Filing)kr3.05M
Total Debt (Recent Filing)kr77.43M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding183,219,120
10 Day Avg. Volume18,569
30 Day Avg. Volume87,893
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.13
Revenue Forecast (FY)kr113.00M
Bulls Say, Bears Say
Bulls Say
Proprietary Bio-based ChemistryOrganoClick’s proprietary bio-based chemistry is a structural competitive asset: it enables product differentiation across wood, textile and material treatments, supports technology-based customer lock-in, and aligns with long-term sustainability demand helping durable commercial adoption if scale and quality are maintained.
Operating Cash Flow Turned PositiveA shift to positive operating cash flow signals improving underlying cash generation and operational control. This durable improvement reduces near-term liquidity pressure, increases optionality to fund working capital or capex, and lowers near-term refinancing reliance if the trend sustains.
Product Sales Model With Recurring Industrial DemandThe core business sells specialty formulations into industrial production cycles, creating repeatable revenue from consumable inputs and treated materials. This business model fosters recurring orders and customer integration, a durable revenue base if adoption and supply scalability persist.
Bears Say
Declining Revenue TrendSustained top-line decline across multiple years indicates structural demand or commercial execution challenges. Over time this reduces scale benefits, limits ability to invest in R&D and distribution, and undermines margin recovery unless product-market fit or go-to-market execution materially improves.
Very High Financial LeverageA ~5.5x debt-to-equity position materially constrains financial flexibility; high leverage raises refinancing and interest coverage risk, reduces ability to absorb shocks, and forces prioritization of cash to service debt rather than fund growth — a persistent structural constraint on strategy.
Negative Margins And Free Cash FlowDeep negative net margins and ongoing negative free cash flow mean the business is not yet self-funding. Persisting losses erode equity, necessitate external financing, and limit reinvestment capacity. Without margin expansion or durable FCF improvement, operational sustainability is at risk.
OrganoClick AB News
ORGC FAQ
What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was kr0.30 and its highest was kr2.07 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is kr87.76M.
When is OrganoClick AB’s upcoming earnings report date?
OrganoClick AB’s upcoming earnings report date is Aug 12, 2026 which is in 15 days.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on May 06, 2026. The company reported -kr0.015 earnings per share for the quarter, beating the consensus estimate of -kr0.02 by kr0.005.
Is OrganoClick AB overvalued?
According to Wall Street analysts OrganoClick AB’s price is currently Overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 183,219,120 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -kr0.015 in its last earnings report, beating expectations of -kr0.02. Following the earnings report the stock price went up 6.371%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in SE:ORGC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OrganoClick AB
OrganoClick AB (publ), a technology firm based in Täby, Sweden, was established in 2006. The company specializes in the development, production, and sale of innovative fiber-based materials and chemicals for applications spanning wood treatment, technical textiles, nonwovens, and biocomposites. Its diverse product portfolio includes OrganoWood, a wood preservation system that enhances wood's resistance to both rot and fire, primarily serving the construction industry and consumers. OrganoTex offers a biodegradable durable water repellent (DWR) technology for textiles, alongside related shoe and clothing care items. Additionally, OrganoComp is a biobased, plastic-free, and compostable composite designed to replace rigid plastics in 3D-molded products. For consumers, the BIOkleen brand provides a range of maintenance and cleaning solutions for wood, facades, roofs, terraces, and car care. Industrial clients benefit from OC-BioBinder, a biodegradable and plastic-free binder used in nonwovens and technical textiles as an alternative to conventional plastic binders, and OC-AquaSil Tex, a biodegradable water-repelling product that replaces PFAS chemicals in nonwovens, specialty papers, and technical textiles.
Technical Analysis
Nexam Chemical Holding AB
―
Svenska Aerogel Holding AB
―
Polygiene AB
―
Impact Coatings AB
―
XP Chemistries AB
―